Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Polonsky

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of Diabetes Science and Technology|July 28, 2023
Treatment Satisfaction and Well-Being With Continuous Glucose Monitoring in People With Type 1 Diabetes: An Analysis Based on the GOLD Randomized TrialDaniel Pylov, William Polonsky, Henrik Imberg, et al.
Diabetes Technology & Therapeutics|April 3, 2018
A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)Arndís F Ólafsdóttir, William Polonsky, Jan Bolinder, et al.
JAMA|January 25, 2017
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical TrialMarcus Lind, William Polonsky, Irl B Hirsch, et al.
JAMA|January 25, 2017
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical TrialRoy W Beck, Tonya Riddlesworth, Katrina Ruedy, et al.
Diabetes, Obesity & Metabolism|November 17, 2020
The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5)Arndís F Ólafsdóttir, Jan Bolinder, Tim Heise, et al.
Diabetes Care|July 10, 2020
The Association Between HbA<sub>1c</sub> and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)Shilan Seyed Ahmadi, Klara Westman, Aldina Pivodic, et al.
Annals of Internal Medicine|August 23, 2017
Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized TrialRoy W Beck, Tonya D Riddlesworth, Katrina Ruedy, et al.
Diabetologia|April 26, 2024
Discordance between mean glucose and time in range in relation to HbA<sub>1c</sub> in individuals with type 1 diabetes: results from the GOLD and SILVER trialsSofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, et al.
Journal of Diabetes Science and Technology|January 10, 2012
Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetesDavid C Klonoff, Lawrence Blonde, George Cembrowski, et al.
The Lancet. Diabetes & Endocrinology|July 17, 2017
Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trialRoy W Beck, Tonya D Riddlesworth, Katrina J Ruedy, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Diabetes Science and Technology|July 28, 2023
Treatment Satisfaction and Well-Being With Continuous Glucose Monitoring in People With Type 1 Diabetes: An Analysis Based on the GOLD Randomized TrialDaniel Pylov, William Polonsky, Henrik Imberg, et al.
Diabetes Technology & Therapeutics|April 3, 2018
A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)Arndís F Ólafsdóttir, William Polonsky, Jan Bolinder, et al.
JAMA|January 25, 2017
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical TrialMarcus Lind, William Polonsky, Irl B Hirsch, et al.
JAMA|January 25, 2017
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical TrialRoy W Beck, Tonya Riddlesworth, Katrina Ruedy, et al.
Diabetes, Obesity & Metabolism|November 17, 2020
The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5)Arndís F Ólafsdóttir, Jan Bolinder, Tim Heise, et al.
Diabetes Care|July 10, 2020
The Association Between HbA<sub>1c</sub> and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)Shilan Seyed Ahmadi, Klara Westman, Aldina Pivodic, et al.
Annals of Internal Medicine|August 23, 2017
Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized TrialRoy W Beck, Tonya D Riddlesworth, Katrina Ruedy, et al.
Diabetologia|April 26, 2024
Discordance between mean glucose and time in range in relation to HbA<sub>1c</sub> in individuals with type 1 diabetes: results from the GOLD and SILVER trialsSofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, et al.
Journal of Diabetes Science and Technology|January 10, 2012
Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetesDavid C Klonoff, Lawrence Blonde, George Cembrowski, et al.
The Lancet. Diabetes & Endocrinology|July 17, 2017
Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trialRoy W Beck, Tonya D Riddlesworth, Katrina J Ruedy, et al.
Pageof 5